Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 30,956Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16BAYER HEALTHCARE

02 26BAYER HLTHCARE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 10047097

Drug Substance Claim :

Drug Product Claim :

Application Number : 211710

Patent Use Code : U-2474

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 8865698

Drug Substance Claim :

Drug Product Claim :

Application Number : 211710

Patent Use Code : U-2469

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 10005783

Drug Substance Claim :

Drug Product Claim :

Application Number : 211710

Patent Use Code : U-2472

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 10047097

Drug Substance Claim :

Drug Product Claim :

Application Number : 210861

Patent Use Code : U-2474

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 9447104

Drug Substance Claim :

Drug Product Claim :

Application Number : 210861

Patent Use Code : U-2470

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 10045991

Drug Substance Claim :

Drug Product Claim :

Application Number : 211710

Patent Use Code : U-2473

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-04-04

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 9782414

Drug Substance Claim :

Drug Product Claim :

Application Number : 211710

Patent Use Code : U-2471

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-16

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 9447104

Drug Substance Claim :

Drug Product Claim :

Application Number : 211710

Patent Use Code : U-2470

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 8865698

Drug Substance Claim :

Drug Product Claim :

Application Number : 210861

Patent Use Code : U-2469

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

LAROTRECTINIB SULFATE

US Patent Number : 10005783

Drug Substance Claim :

Drug Product Claim :

Application Number : 210861

Patent Use Code : U-2472

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-10-21

blank